Invasive Ductal Carcinoma: Shelby's Patient Story
This breast cancer diagnosis at a glance
- Subtype
- Invasive Ductal Carcinoma
- Sex
- Female
- Treatment
- surgery and chemotherapy
- Outcome
- Care Ongoing
Treatment course, step by step
- Had double mastectomy at 21 weeks pregnant
- Received AC chemotherapy during the second and third trimesters while continuing the surrogate pregnancy
- Later delivered a healthy baby
- Radiation, targeted therapy, immunotherapy, and clinical-trial treatment were not reported in this record.
What happened, in summary
Shelby was 34 and 15 weeks pregnant as a first-time surrogate when she felt a sudden lump in her armpit. At first, she thought it might be related to IVF hormones or pregnancy changes. An ultrasound and biopsy instead showed invasive ductal carcinoma, forcing her to balance cancer treatment with the safety of the baby she was carrying for another family. Shelby had to tell the intended parents that she had breast cancer while still carrying their child. Her care team moved forward with treatment during pregnancy. At 21 weeks, she had a double mastectomy. She then received AC chemotherapy during the second and third trimesters, a plan chosen so she could be treated while continuing the pregnancy. The treatment took a visible and emotional toll, including the loss of her breasts and hair. At the same time, Shelby described a growing respect for what her body could do: fight cancer and nurture a baby at once. She also had to explain illness to her own children while coping with fear, uncertainty, and major body changes. She later delivered a healthy baby. As of June 2026, Shelby’s story centered on cancer treatment during surrogacy and the resilience needed to protect both lives.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer